Avalo Therapeutics, Inc.
AVTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534120
In the last 90 days, Avalo Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $1.31B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Avalo Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- +4 vs. Q4 2022
- Shares held
- 9.13M
- +3.58M (+64.5%) vs. Q4 2022
- Total value
- $16.0M
- −$12.0M (−42.9%) vs. Q4 2022
- New holders
- 8
- 9 more added
- Sold out
- 4
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 126 | $1.31B |
| Q1 2026 | 97 | $469.6M |
| Q4 2025 | 84 | $361.1M |
| Q3 2025 | 66 | $194.7M |
| Q2 2025 | 36 | $39.1M |
| Q1 2025 | 34 | $66.1M |
| Q4 2024 | 33 | $56.0M |
| Q3 2024 | 29 | $63.2M |
| Q2 2024 | 21 | $9.62M |
| Q1 2024 | 18 | $1.90M |
| Q4 2023 | 12 | $209.4K |
| Q3 2023 | 28 | $158.9K |
| Q2 2023 | 26 | $862.7K |
| Q1 2023 | 32 | $16.0M |
| Q4 2022 | 28 | $28.0M |
| Q3 2022 | 27 | $18.4M |
| Q2 2022 | 54 | $34.7M |
| Q1 2022 | 71 | $56.2M |
| Q4 2021 | 75 | $136.0M |
| Q3 2021 | 77 | $175.5M |
| Q2 2021 | 71 | $218.1M |
| Q1 2021 | 70 | $180.4M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Avalo Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 4,415,000 | $7.73M | 0.18% | +450,334+11.4% | Added |
| Point72 Asset Management, L.P. | 1,100,737 | $1.93M | 0.01% | +600,000+119.8% | Added |
| VR Adviser, LLC | 1,000,000 | $1.75M | 0.34% | +1,000,000 | New |
| Nantahala Capital Management, LLC | 808,844 | $1.42M | 0.14% | +268,177+49.6% | Added |
| Great Point Partners LLC | 474,639 | $830.6K | 0.16% | +474,639 | New |
| Alyeska Investment Group, L.P. | 400,000 | $700.0K | 0.01% | +400,000 | New |
| Braidwell LP | 247,254 | $432.7K | 0.01% | +247,254 | New |
| Vanguard Group Inc | 222,073 | $388.6K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 103,084 | $180.4K | 0.00% | −145−0.1% | Reduced |
| Maven Securities LTD | 92,937 | $162.6K | 0.03% | +92,937 | New |
| Millennium Management LLC | 62,319 | $109.0K | 0.00% | +19,126+44.3% | Added |
| Monashee Investment Management LLC | 60,000 | $105.0K | 0.03% | +60,000 | New |
| Geode Capital Management, LLC | 51,332 | $89.8K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 32,261 | $56.5K | 0.00% | −847−2.6% | Reduced |
| State Street Corp | 25,643 | $44.9K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 12,326 | $21.6K | 0.00% | −99−0.8% | Reduced |
| Northern Trust Corp | 10,836 | $19.0K | 0.00% | −19−0.2% | Reduced |
| Bank of America Corp | 4,308 | $7.54K | 0.00% | +4,298+42,980.0% | Added |
| UBS Group AG | 2,350 | $4.11K | 0.00% | −3,827−62.0% | Reduced |
| Tower Research Capital LLC (TRC) | 2,503 | $4.00K | 0.00% | +2,417+2,810.5% | Added |
| Royal Bank of Canada | 1,263 | $2.00K | 0.00% | +847+203.6% | Added |
| Advisor Group Holdings, Inc. | 334 | $584 | 0.00% | +333+33,300.0% | Added |
| First Horizon Advisors, Inc. | 276 | $483 | 0.00% | +276 | New |
| TCI Wealth Advisors, Inc. | 251 | $440 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 174 | $305 | 0.00% | −9−4.9% | Reduced |
| Wells Fargo & Company | 158 | $277 | 0.00% | +27+20.6% | Added |
| Meeder Asset Management Inc | 62 | $109 | 0.00% | −1,445−95.9% | Reduced |
| Newbridge Financial Services Group, Inc. | 10 | $18 | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 6 | $10 | 0.00% | 00.0% | Unchanged |
| Kistler-Tiffany Companies, LLC | 2 | $4 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 101 | $0 | 0.00% | +101 | New |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −18,671−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −15,646−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |